RecruitingNCT04837352

Therapeutic Adherence of Multiple Sclerosis Patients

Obstacles and Levers of the Therapeutic Adherence of Multiple Sclerosis Patients


Sponsor

Lille Catholic University

Enrollment

153 participants

Start Date

Jan 18, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this study is to assess the role of sociocognitive and interpersonal factors in the therapeutic adherence of multiple sclerosis patients. This study will provide a better understanding of the socio-psychological issues associated with different types of non-adherence to treatment, and identify the risk factors and vulnerability of each patient.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Multiple sclerosis defined according to McDonald criteria;
  • Already undergone or beginning substantive treatment (self-managed, excluding treatment administered in hospital)
  • Aged ≥ 18 years;
  • Given the informed consent form.

Exclusion Criteria3

  • Severe cognitive impairment (score below the 5th percentile);
  • Any associated neurological pathology or serious or chronic somatic disease (cancer);
  • Being under a legal protection measure.

Interventions

OTHERStudy of the role of sociocognitive factors

Questionnaires


Locations(4)

CHRU DE Bordeaux

Bordeaux, France

Hôpital Saint-Vincent de Paul

Lille, France

Hôpital Saint-Philibert

Lomme, France

CHRU de Strasbourg

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04837352


Related Trials